Human trial evidence does not yet exist
Vukojevic J, Milavic M, Perovic D, et al
For that reason, an untreated pernicious anemia often leads to neurological damage, which should explain why so many patients with neurological disorders such as Alzheimer, multiple sclerosis, peripheral neuropathy, and Bells Palsy, benefit from B12 shots
Beyond these clinical studies, Jeuveau was first introduced to the Korean market in 2014 under the name Nabota, and so we have some good data as well about what happens when Jeuveau is used outside of closely controlled scientific studies
Two additional brief but important points
Its our preferred way to inject B12, especially if you self-inject, and againtheres no muscle pain after B12 shots done this way